Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Disrupted brain metabolic connectivity in a 6-OHDA-induced mouse model of Parkinson's disease examined using persistent homology-based analysis.

Im HJ, Hahm J, Kang H, Choi H, Lee H, Hwang do W, Kim EE, Chung JK, Lee DS.

Sci Rep. 2016 Sep 21;6:33875. doi: 10.1038/srep33875.

2.

Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.

Felger JC, Treadway MT.

Neuropsychopharmacology. 2017 Jan;42(1):216-241. doi: 10.1038/npp.2016.143.

PMID:
27480574
3.

A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism.

Niccolini F, Politis M.

Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2244-2254. Review.

4.

Metabolic Covariant Network in Relation to Nigrostriatal Degeneration in Carbon Monoxide Intoxication-Related Parkinsonism.

Chang CC, Hsu JL, Chang WN, Huang SH, Huang CW, Chang YT, Chen NC, Lui CC, Lee CC, Hsu SW.

Front Neurosci. 2016 May 3;10:187. doi: 10.3389/fnins.2016.00187.

5.

Pedunculopontine arousal system physiology - Deep brain stimulation (DBS).

Garcia-Rill E, Luster B, D'Onofrio S, Mahaffey S, Bisagno V, Urbano FJ.

Sleep Sci. 2015 Nov;8(3):153-61. doi: 10.1016/j.slsci.2015.09.001. Review.

6.

Low Cerebral Glucose Metabolism: A Potential Predictor for the Severity of Vascular Parkinsonism and Parkinson's Disease.

Xu Y, Wei X, Liu X, Liao J, Lin J, Zhu C, Meng X, Xie D, Chao D, Fenoy AJ, Cheng M, Tang B, Zhang Z, Xia Y, Wang Q.

Aging Dis. 2015 Nov 17;6(6):426-36. doi: 10.14336/AD.2015.0204.

7.

Primary motor cortex of the parkinsonian monkey: altered encoding of active movement.

Pasquereau B, DeLong MR, Turner RS.

Brain. 2016 Jan;139(Pt 1):127-43. doi: 10.1093/brain/awv312.

8.

Cerebral perfusion and cortical thickness indicate cortical involvement in mild Parkinson's disease.

Madhyastha TM, Askren MK, Boord P, Zhang J, Leverenz JB, Grabowski TJ.

Mov Disord. 2015 Dec;30(14):1893-900. doi: 10.1002/mds.26128.

9.

Insights from the supplementary motor area syndrome in balancing movement initiation and inhibition.

Potgieser AR, de Jong BM, Wagemakers M, Hoving EW, Groen RJ.

Front Hum Neurosci. 2014 Nov 28;8:960. doi: 10.3389/fnhum.2014.00960. Erratum in: Front Hum Neurosci. 2015;9:19.

10.

Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.

Hirao K, Pontone GM, Smith GS.

Neurosci Biobehav Rev. 2015 Feb;49:157-70. doi: 10.1016/j.neubiorev.2014.11.010. Review.

11.

Sensorimotor connectivity in Parkinson's disease: the role of functional neuroimaging.

Tessitore A, Giordano A, De Micco R, Russo A, Tedeschi G.

Front Neurol. 2014 Sep 24;5:180. doi: 10.3389/fneur.2014.00180. Review.

12.

The metabolic brain network in patients with Parkinson's disease based on (18)F-FDG PET imaging: evaluation of neuronal injury and regeneration.

Ge J, Wu P, Zuo C.

Neural Regen Res. 2014 Apr 1;9(7):763-5. doi: 10.4103/1673-5374.131586. No abstract available.

13.

The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes.

Holtbernd F, Eidelberg D.

Semin Neurol. 2014 Apr;34(2):202-9. doi: 10.1055/s-0034-1381733. Review.

14.

Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.

González-Redondo R, García-García D, Clavero P, Gasca-Salas C, García-Eulate R, Zubieta JL, Arbizu J, Obeso JA, Rodríguez-Oroz MC.

Brain. 2014 Aug;137(Pt 8):2356-67. doi: 10.1093/brain/awu159.

15.

Differential Diagnosis of Parkinsonism Using Dual-Phase F-18 FP-CIT PET Imaging.

Jin S, Oh M, Oh SJ, Oh JS, Lee SJ, Chung SJ, Lee CS, Kim JS.

Nucl Med Mol Imaging. 2013 Mar;47(1):44-51. doi: 10.1007/s13139-012-0182-4.

16.

The effects of methylphenidate on resting-state striatal, thalamic and global functional connectivity in healthy adults.

Farr OM, Zhang S, Hu S, Matuskey D, Abdelghany O, Malison RT, Li CS.

Int J Neuropsychopharmacol. 2014 Aug;17(8):1177-91. doi: 10.1017/S1461145714000674.

17.

Characterization of disease-related covariance topographies with SSMPCA toolbox: effects of spatial normalization and PET scanners.

Peng S, Ma Y, Spetsieris PG, Mattis P, Feigin A, Dhawan V, Eidelberg D.

Hum Brain Mapp. 2014 May;35(5):1801-14. doi: 10.1002/hbm.22295.

18.

Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.

Felger JC, Mun J, Kimmel HL, Nye JA, Drake DF, Hernandez CR, Freeman AA, Rye DB, Goodman MM, Howell LL, Miller AH.

Neuropsychopharmacology. 2013 Oct;38(11):2179-87. doi: 10.1038/npp.2013.115.

19.

Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

Felger JC, Lotrich FE.

Neuroscience. 2013 Aug 29;246:199-229. doi: 10.1016/j.neuroscience.2013.04.060. Review.

20.

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.

Miller AH, Haroon E, Raison CL, Felger JC.

Depress Anxiety. 2013 Apr;30(4):297-306. doi: 10.1002/da.22084. Review.

Items per page

Supplemental Content

Support Center